INSIGHTS ON SOLID DOSE MANUFACTURING

• Advancements In GLP-1 Analog Formulation: Overcoming Challenges

  Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

• Low-Bioburden Powders For Terminal Sterilisation

  Low‑bioburden powders for reconstitution demand strict microbial control, advanced formulation, and specialised manufacturing, making CDMO expertise vital for modern biopharma.

• Future Of Pharma Packaging: Trends, Tech, And Patient Solutions

  Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.

• Modeling Polymer Interactions To Improve Amorphous Solid Dispersion Stability

  Molecular dynamics modeling revealed how hydrogen bonding between PVP and Eudragit drives stable amorphous solid dispersion formation, cutting formulation screening time significantly.

• Advances In Oral GLP-1 Analogs For Obesity

  9/12/2024

  Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.

• Bottling Solutions

  3/4/2025

  Explore a bottling solution that is meticulously engineered to adhere to the most stringent pharmaceutical standards, which guarantees that each product is crafted with unparalleled quality and precision.

• Blending And Simulation: A Beginner's Guide

  2/26/2025

  This beginner-friendly webinar reveals essential steps to understand mixing, reduce segregation, enhance efficiency, and improve product quality with granular materials.

• Bridging The Gap Between Product Readiness And Equipment Availability

  12/15/2025

  Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.

• Predicting Drug-Loading Limits In Tablet Formulations

  7/15/2026

  Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.